Suppr超能文献

贲门失弛缓症患者的自身免疫合并症。

Autoimmune comorbidity in achalasia patients.

机构信息

Department of Experimental Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

出版信息

J Gastroenterol Hepatol. 2018 Jan;33(1):203-208. doi: 10.1111/jgh.13839.

Abstract

BACKGROUND AND AIM

Idiopathic achalasia is a rare esophageal motor disorder. The disease state manifests local and systemic inflammation, and it appears that an autoimmune component and specific autoantibodies participate in the pathogenesis. The study aims to determine the prevalence of autoimmune and chronic inflammatory diseases in patients with achalasia and compare the results with those from patients with gastroesophageal reflux disease (GERD).

METHODS

It was a cross-sectional and included 114 patients with idiopathic achalasia and 114 age-matched and sex-matched control patients with GERD. Data on the presence of autoimmune and inflammatory diseases, the time of presentation, and any family history of autoimmune disease were obtained from the hospital's medical records.

RESULTS

Seventy three (64%) were female patients (mean age: 42.3 ± 15.5; median disease duration: 12 months). We identified the presence of autoimmune disease in 19 patients with achalasia (16.7%), hypothyroidism was the main diagnosis, and it was present in 52.6% of patients compared with 4.2% in controls. Thirteen of the 19 achalasia patients (68.4%) with autoimmune disease had history of familial autoimmunity. We identified 11 achalasia (9.6%) and 5 GERD patients (4.16%) with an inflammatory condition. Compared with the GERD, the achalasia group was 3.8 times more likely to have an autoimmune disease (95% CI: 1.47-9.83), 3.0 times more likely to have thyroidopathies (95% CI: 1.00-9.03), and 3.02 times more likely to suffer from any chronic inflammatory disease (95% CI: 1.65-6.20).

CONCLUSIONS

The non-negligible number of patients with autoimmune diseases identified among the patients with idiopathic achalasia supports the hypothesis that achalasia has an autoimmune component.

摘要

背景与目的

特发性贲门失弛缓症是一种罕见的食管动力障碍。这种疾病表现为局部和全身炎症,似乎有一种自身免疫成分和特定的自身抗体参与了发病机制。本研究旨在确定贲门失弛缓症患者自身免疫和慢性炎症性疾病的患病率,并将结果与胃食管反流病(GERD)患者进行比较。

方法

这是一项横断面研究,纳入了 114 例特发性贲门失弛缓症患者和 114 例年龄和性别匹配的 GERD 对照患者。从医院病历中获取自身免疫和炎症性疾病的存在、发病时间以及任何自身免疫性疾病家族史的数据。

结果

73 例(64%)为女性患者(平均年龄:42.3±15.5;中位疾病持续时间:12 个月)。我们在 19 例贲门失弛缓症患者(16.7%)中发现了自身免疫性疾病,主要诊断为甲状腺功能减退症,其在患者中的患病率为 52.6%,而对照组为 4.2%。19 例贲门失弛缓症自身免疫性疾病患者中有 13 例(68.4%)有家族自身免疫病史。我们发现 11 例贲门失弛缓症(9.6%)和 5 例 GERD 患者(4.16%)存在炎症性疾病。与 GERD 相比,贲门失弛缓症组发生自身免疫性疾病的可能性高 3.8 倍(95%CI:1.47-9.83),发生甲状腺疾病的可能性高 3.0 倍(95%CI:1.00-9.03),发生任何慢性炎症性疾病的可能性高 3.02 倍(95%CI:1.65-6.20)。

结论

在特发性贲门失弛缓症患者中发现的自身免疫性疾病数量不容忽视,这支持了贲门失弛缓症存在自身免疫成分的假说。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验